ArticleJournal of cancer research and clinical oncology2022

Docetaxel enhances the therapeutic efficacy of PSMA-specific CAR-T cells against prostate cancer models by suppressing MDSCs.

Xiaokang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.